12 departmental wall charts
Cinquième Enquête Démographique et de Santé au Bénin (EDSB-V) 2017-2018
Final Report
Submitted to: Unicef, New Delhi
ORG Centre for Social Research (A Division of AC Nielsen ORG- MARG Private Limited)
Accessed: 30.10.2019
Case Study
Accessed: 30.10.2019
PLOS ONE | https://doi.org/10.1371/journal.pone.0217693 June 7, 2019
12 departmental wall charts
12 Departmental Wall Charts
Journal of Infection and Public Health 12 (2019) 213–223
This rapid compilation of data analyses provides a ‘stock-take’ of social science and behavioural data related to the on-going outbreak of Ebola in North Kivu, South Kivu and Ituri provinces. Based on data gathered and analysed by organisations working in the Ebola response and in the region mor...e broadly, it explores convergences and divergences between datasets and, when possible, differences by geographic area, demographic group, time period and other relevant variables. Data sources are listed at the end of the document.
more
In 2017 Hurricane Maria devastated the Caribbean island of Puerto Rico. “After Maria” is based on a one-year ethnographic research project about how 16 low-income Puerto Rican families were affected by, and recovered from the impacts of Maria. Dr. Gemma Sou visited Puerto Rico five times during ...the first year after Maria, to chat candidly about how the families were recovering. Although this graphic novella tells the story of a fictional family, “After Maria” is based on the experiences that tie together all of the Puerto Rican families that I spoke to.
more
Problems with care for older people with dementia in Australia “Fading Away”: How Aged Care Facilities in Australia Chemically Restrain Older People with Dementia
Revised working paper following AVAREF meeting February 2019.
WHO has published a roadmap aiming to coordinate partners’ actions and contributions to the licensing and roll-out of Merck’s Ebola vaccine (VSV-ZEBOV) in African countries. The vaccine was developed during the West Africa Ebola epi...demic of 2014-2016, during which more than 11 000 people lost their lives to the disease. The vaccine was tested in European and African countries at the time and is currently used under an “expanded access” protocol in the Democratic Republic of Congo.
WHO will expedite prequalification and licensing of the vaccine for use in countries at risk of Ebola outbreaks and will coordinate work between those countries’ regulatory authorities and the European Medicines Agency and the US Food and Drug Administration.
more